ATB Cormark Capital Markets Lowers Kits Eyecare (TSE:KITS) Price Target to C$16.75

Kits Eyecare (TSE:KITS) had its target price cut by equities research analysts at ATB Cormark Capital Markets from C$20.00 to C$16.75 in a report issued on Thursday,BayStreet.CA reports. The brokerage currently has a “speculative buy” rating on the stock. ATB Cormark Capital Markets’ price target would suggest a potential upside of 46.54% from the stock’s current price.

Kits Eyecare Trading Down 7.7%

Shares of KITS traded down C$0.95 during midday trading on Thursday, reaching C$11.43. The stock had a trading volume of 306,356 shares, compared to its average volume of 115,911. The firm has a market capitalization of C$388.51 million, a price-to-earnings ratio of 127.00 and a beta of 0.46. Kits Eyecare has a 1-year low of C$11.12 and a 1-year high of C$22.56.

Kits Eyecare (TSE:KITS) last issued its earnings results on Wednesday, May 6th. The company reported C$0.06 EPS for the quarter. The firm had revenue of C$57.47 million for the quarter.

About Kits Eyecare

KITS (TSX: KITS) is one of the world’s fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.